Search

CLABSI rate decreased by over 40%

“We decreased our CLABSI rate by over 40% from 2021 (1.6 per 1,000 line days) to the fourth quarter of 2022 (0.91) and kept the rate below or around the national rate (0.86) for the last three quarters of 2022” Bohan et al (2024).

Read More »

Vascular access for long-term parenteral nutrition

“Securing safe and effective intravenous (IV) access is of utmost importance for administering parenteral nutrition (PN). Sustaining this access can indeed pose challenges, especially when dealing with the risk of complications associated with long-term PN. This review emphasizes best practices to optimize intravenous access and reviews the current evidence-based recommendations and consensus guidelines” Hurt et al (2024).

Read More »

Post CLABSI antimicrobial de-escalation

“An institutional protocol was developed for the evaluation and empirical antibiotic treatment of possible CLABSIs. The potential impact of de-escalating antimicrobial therapy based on initial Gram stain and molecular identification was assessed” Beckman et al (2024).

Read More »

Implantable port site complications post bevacizumab infusion

“The results of this study show an inverse relationship between the risk of wound dehiscence and port site complication and the timing of bevacizumab infusion to port placement, with an increase in absolute risk of wound dehiscence when bevacizumab is given within 2 days of port placement” Yun et al (2024).

Read More »

Proposal for the development of German central venous access guidelines

“In our opinion, the most needed recommendation for central venous access is to utilize ultrasound guidance, a practice that many international societies have already incorporated into their published national guidelines. In our view, it is time to implement a national guideline for central venous access using ultrasound in Germany” Armbruster et al (2024).

Read More »

Mycobacterium senegalense CLABSI diagnosis and management

“Blood cultures from a permanent catheter and peripheral taken concurrently yielded Mycobacterium senegalense, identified by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry, which established the diagnosis of CRBSI atypically presented with concurrent acute intracranial bleeding and cerebrovascular infarction at initial presentation” Badarol Hisham et al (2024).

Read More »

OPAT patient experience in Germany – Full Text

“Because OPAT has been used only sporadically in Germany so far, no structured results on patients’ experiences and concerns regarding OPAT have yet been available. This study therefore aims to explore the experiences of OPAT patients in a pilot region in Germany” Oberröhrmann et al (2024).

Read More »

CLABSI rate decreased by over 40%

“We decreased our CLABSI rate by over 40% from 2021 (1.6 per 1,000 line days) to the fourth quarter of 2022 (0.91) and kept the rate below or around the national rate (0.86) for the last three quarters of 2022” Bohan et al (2024).

Read More »

Vascular access for long-term parenteral nutrition

“Securing safe and effective intravenous (IV) access is of utmost importance for administering parenteral nutrition (PN). Sustaining this access can indeed pose challenges, especially when dealing with the risk of complications associated with long-term PN. This review emphasizes best practices to optimize intravenous access and reviews the current evidence-based recommendations and consensus guidelines” Hurt et al (2024).

Read More »

Post CLABSI antimicrobial de-escalation

“An institutional protocol was developed for the evaluation and empirical antibiotic treatment of possible CLABSIs. The potential impact of de-escalating antimicrobial therapy based on initial Gram stain and molecular identification was assessed” Beckman et al (2024).

Read More »

Implantable port site complications post bevacizumab infusion

“The results of this study show an inverse relationship between the risk of wound dehiscence and port site complication and the timing of bevacizumab infusion to port placement, with an increase in absolute risk of wound dehiscence when bevacizumab is given within 2 days of port placement” Yun et al (2024).

Read More »

Proposal for the development of German central venous access guidelines

“In our opinion, the most needed recommendation for central venous access is to utilize ultrasound guidance, a practice that many international societies have already incorporated into their published national guidelines. In our view, it is time to implement a national guideline for central venous access using ultrasound in Germany” Armbruster et al (2024).

Read More »

Mycobacterium senegalense CLABSI diagnosis and management

“Blood cultures from a permanent catheter and peripheral taken concurrently yielded Mycobacterium senegalense, identified by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry, which established the diagnosis of CRBSI atypically presented with concurrent acute intracranial bleeding and cerebrovascular infarction at initial presentation” Badarol Hisham et al (2024).

Read More »

OPAT patient experience in Germany – Full Text

“Because OPAT has been used only sporadically in Germany so far, no structured results on patients’ experiences and concerns regarding OPAT have yet been available. This study therefore aims to explore the experiences of OPAT patients in a pilot region in Germany” Oberröhrmann et al (2024).

Read More »

Combination systemic and catheter lock-therapy – Full Text

“The study demonstrates that combining systemic and lock therapies with micafungin effectively eradicates catheter-based biofilms and infections caused by C. albicans or C. parapsilosis, particularly in persistently neutropenic conditions, offering promising implications for managing vascular catheter-related candidemia and providing clinical benefits in cases where catheter removal is not feasible” Petraitiene et al (2024).

Read More »

Pharmacist role in OPAT – Full Text

“The TOC pharmacists can play a key role in the evaluation of OPAT prescriptions at hospital discharge. This intervention demonstrated how TOC pharmacists can effectively collaborate with the OPAT team, which builds on prior evidence of the role and value of pharmacists in the transitional care setting” Stashluk et al (2024).

Read More »